Spinal cord stimulation: a valuable treatment for chronic failed back surgery patients

Journal of Pain and Symptom Management
J DevulderG Rolly

Abstract

Spinal cord stimulation (SCS) has been used in the treatment of "chronic failed back surgery syndrome" for many years. To evaluate long-term results and cost effectiveness of SCS, we interviewed 69 patients treated during a period of 13 years. Twenty-six patients stopped using SCS; there was no clear explanation for this unsatisfactory result in 10. Forty-three patients continued with the therapy and obtained good pain relief. Electrode breakage either spontaneous or due to a procedure to obtain better stimulation paresthesias was more frequent in the radiofrequency-coupled system group than in the battery group (mean +/- SEM 2.81 +/- 2.0 versus 1.42 +/- 1.51, respectively; P = 0.0018). Ten patients obtained better pain relief than during the trial procedure. Some still need opioid analgesics, but 11 of the 16 who require these drugs obtained a synergistic effect when concomitantly using the stimulator. Eleven patients have returned to work. In our center, the application of SCS costs on average $3660 per patient per year. Although this seems expensive, it may be a cost-effective treatment if other therapies fail.

References

Apr 1, 1986·Journal of Behavioral Medicine·W E FordyceD Spengler
Nov 19, 1965·Science·R Melzack, P D Wall
May 1, 1970·Journal of Neurosurgery·C N ShealyN R Hagfors
Feb 1, 1995·British Journal of Rheumatology·D WrightM I Jayson
Jan 1, 1993·Pain·C De La Porte, E Van de Kelft

❮ Previous
Next ❯

Citations

Oct 26, 2001·Current Pain and Headache Reports·T R Deer
Jan 1, 2001·Neuromodulation : Journal of the International Neuromodulation Society·Valerie C AndersonDeborah Shatin
Apr 1, 2001·Neuromodulation : Journal of the International Neuromodulation Society·G BarolatA Sharan
Apr 1, 2002·Neuromodulation : Journal of the International Neuromodulation Society·Kenneth M AlóJeffery Charnov
Jul 1, 2002·Neuromodulation : Journal of the International Neuromodulation Society·Ashwini SharanGiancarlo Barolat
Oct 3, 2006·Current Opinion in Anaesthesiology·B DonnerT Weiss
Oct 24, 2002·Journal of Spinal Disorders & Techniques·A SchoegglC Matula
Jul 20, 2002·Regional Anesthesia and Pain Medicine·David LogéEric Mortier
Sep 1, 2004·The Neurologist·Stephen T Onesti
Jul 1, 1998·Neuromodulation : Journal of the International Neuromodulation Society·K M Alo
Jan 1, 1998·Neuromodulation : Journal of the International Neuromodulation Society·K M AloV Redko
Oct 1, 2006·Neuromodulation : Journal of the International Neuromodulation Society·Michelangelo BuonocoreCesare Bonezzi
Jul 1, 2007·Neuromodulation : Journal of the International Neuromodulation Society·John C OakleyJaimie Henderson
Oct 14, 2011·Neuromodulation : Journal of the International Neuromodulation Society·Elliot S KramesRobert Levy
Oct 22, 2003·The Nursing Clinics of North America·Barbara St Marie
Dec 14, 2006·Pain Practice : the Official Journal of World Institute of Pain·Guy R FogelOctavio Calvillo
Jul 1, 2004·Neuromodulation : Journal of the International Neuromodulation Society·Geert H SpincemaillePeter J Theuvenet
Jan 15, 2010·Pain Practice : the Official Journal of World Institute of Pain·Nagy A MekhailTimothy Deer
Mar 16, 2007·Expert Review of Medical Devices·Antonio FolettiEric Buchser
Sep 22, 2000·Current Review of Pain·S R Anderson
Sep 7, 2017·Asian Spine Journal·Jae Hwan ChoJae-Young Hong
Aug 18, 2018·Neuromodulation : Journal of the International Neuromodulation Society·Maarten MoensJan Verlooy
Jun 25, 2019·Neuromodulation : Journal of the International Neuromodulation Society·Tomasz SzmudaKatarzyna Aleksandrowicz
Nov 26, 2013·The Cochrane Database of Systematic Reviews·Angela Mailis-GagnonRod S Taylor
Dec 7, 2019·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Timothy R DeerJoseph A Sclafani
Jun 24, 2004·Joint Commission Journal on Quality and Safety·Nicoline BeersenNiek S Klazinga

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.